Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 234

1.

Desvenlafaxine and escitalopram for the treatment of postmenopausal women with major depressive disorder.

Soares CN, Thase ME, Clayton A, Guico-Pabia CJ, Focht K, Jiang Q, Kornstein SG, Ninan P, Kane CP, Cohen LS.

Menopause. 2010 Jul;17(4):700-11. doi: 10.1097/gme.0b013e3181d88962.

PMID:
20539246
[PubMed - indexed for MEDLINE]
2.

Open-label treatment with desvenlafaxine in postmenopausal women with major depressive disorder not responding to acute treatment with desvenlafaxine or escitalopram.

Soares CN, Thase ME, Clayton A, Guico-Pabia CJ, Focht K, Jiang Q, Kornstein SG, Ninan PT, Kane CP.

CNS Drugs. 2011 Mar;25(3):227-38. doi: 10.2165/11586460-000000000-00000.

PMID:
21323394
[PubMed - indexed for MEDLINE]
3.

Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.

Tourian KA, Padmanabhan SK, Groark J, Brisard C, Farrington D.

Clin Ther. 2009 Jun;31 Pt 1:1405-23. doi: 10.1016/j.clinthera.2009.07.006.

PMID:
19698901
[PubMed - indexed for MEDLINE]
4.

Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorder.

Liebowitz MR, Manley AL, Padmanabhan SK, Ganguly R, Tummala R, Tourian KA.

Curr Med Res Opin. 2008 Jul;24(7):1877-90. doi: 10.1185/03007990802161923 . Epub 2008 May 27.

PMID:
18507895
[PubMed - indexed for MEDLINE]
5.

Short-term efficacy and safety of desvenlafaxine in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder.

Kornstein SG, Jiang Q, Reddy S, Musgnung JJ, Guico-Pabia CJ.

J Clin Psychiatry. 2010 Aug;71(8):1088-96. doi: 10.4088/JCP.10m06018blu.

PMID:
20797382
[PubMed - indexed for MEDLINE]
6.

Clinical utility of desvenlafaxine 50 mg/d for treating MDD: a review of two randomized placebo-controlled trials for the practicing physician.

Reddy S, Kane C, Pitrosky B, Musgnung J, Ninan PT, Guico-Pabia CJ.

Curr Med Res Opin. 2010 Jan;26(1):139-50. doi: 10.1185/03007990903408678. Review.

PMID:
19919295
[PubMed - indexed for MEDLINE]
7.

[Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].

Azorin JM, Llorca PM, Despiegel N, Verpillat P.

Encephale. 2004 Mar-Apr;30(2):158-66. French.

PMID:
15107719
[PubMed - indexed for MEDLINE]
8.

Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.

Khan A, Bose A, Alexopoulos GS, Gommoll C, Li D, Gandhi C.

Clin Drug Investig. 2007;27(7):481-92.

PMID:
17563128
[PubMed - indexed for MEDLINE]
9.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
[PubMed - indexed for MEDLINE]
10.

Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.

Yevtushenko VY, Belous AI, Yevtushenko YG, Gusinin SE, Buzik OJ, Agibalova TV.

Clin Ther. 2007 Nov;29(11):2319-32.

PMID:
18158074
[PubMed - indexed for MEDLINE]
11.

Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.

Kennedy SH, Andersen HF, Lam RW.

J Psychiatry Neurosci. 2006 Mar;31(2):122-31. Erratum in: J Psychiatry Neurosci. 2006 Jul;31(4):228.

PMID:
16575428
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder.

Bielski RJ, Ventura D, Chang CC.

J Clin Psychiatry. 2004 Sep;65(9):1190-6.

PMID:
15367045
[PubMed - indexed for MEDLINE]
13.

Escitalopram in major depressive disorder: a multicenter, randomized, double-blind, fixed-dose, parallel trial in a Chinese population.

Mao PX, Tang YL, Jiang F, Shu L, Gu X, Li M, Qian M, Ma C, Mitchell PB, Cai ZJ.

Depress Anxiety. 2008;25(1):46-54.

PMID:
17149753
[PubMed - indexed for MEDLINE]
14.

[Escitalopram for treatment of major depressive disorder in adults].

Llorca PM, Brousse G, Schwan R.

Encephale. 2005 Jul-Aug;31(4 Pt 1):490-501. Review. French.

PMID:
16389716
[PubMed - indexed for MEDLINE]
15.

Analysis by age and sex of efficacy data from placebo-controlled trials of desvenlafaxine in outpatients with major depressive disorder.

Kornstein SG, Clayton AH, Soares CN, Padmanabhan SK, Guico-Pabia CJ.

J Clin Psychopharmacol. 2010 Jun;30(3):294-9. doi: 10.1097/JCP.0b013e3181dcb594.

PMID:
20473066
[PubMed - indexed for MEDLINE]
16.

Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis.

Lam RW, Lönn SL, Despiégel N.

Int Clin Psychopharmacol. 2010 Jul;25(4):199-203. doi: 10.1097/YIC.0b013e32833948d8.

PMID:
20357664
[PubMed - indexed for MEDLINE]
17.

Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.

Pigott TA, Prakash A, Arnold LM, Aaronson ST, Mallinckrodt CH, Wohlreich MM.

Curr Med Res Opin. 2007 Jun;23(6):1303-18. Epub 2007 Apr 27.

PMID:
17559729
[PubMed - indexed for MEDLINE]
18.

Escitalopram for comorbid depression and anxiety in elderly patients: A 12-week, open-label, flexible-dose, pilot trial.

Mohamed S, Osatuke K, Aslam M, Kasckow J.

Am J Geriatr Pharmacother. 2006 Sep;4(3):201-9.

PMID:
17062320
[PubMed - indexed for MEDLINE]
19.

Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.

Clayton AH, Croft HA, Horrigan JP, Wightman DS, Krishen A, Richard NE, Modell JG.

J Clin Psychiatry. 2006 May;67(5):736-46.

PMID:
16841623
[PubMed - indexed for MEDLINE]
20.

Escitalopram maintenance treatment for prevention of recurrent depression: a randomized, placebo-controlled trial.

Kornstein SG, Bose A, Li D, Saikali KG, Gandhi C.

J Clin Psychiatry. 2006 Nov;67(11):1767-75.

PMID:
17196058
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk